{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:35:57Z","timestamp":1790516157446,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/pas.0000000000000523","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T11:34:06Z","timestamp":1443699246000},"page":"192-201","source":"Crossref","is-referenced-by-count":45,"title":["NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease"],"prefix":"10.1097","volume":"40","author":[{"given":"Daniel","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Martinez-Trillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Molina-Urra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Gonzalez-Farre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Salaverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Enjuanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem","family":"Clot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Carrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Villamor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Colomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wotherspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella","family":"Matutes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210131","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3324\/haematol.2009.013714","article-title":". Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features.","volume":"95","author":"Kanellis","year":"2010","journal-title":"Haematologica"},{"key":"R3-5-20210131","first-page":"22","article-title":"Mateo MS, et al..","volume":"40","author":"Mollejo","year":"2002","journal-title":"Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma Histopathology"},{"key":"R4-5-20210131","first-page":"2253","article-title":"Bauchu EC, et al..","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity Blood"},{"key":"R5-5-20210131","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":". BRAF mutations in hairy-cell leukemia.","volume":"364","author":"Tiacci","year":"2011","journal-title":"N Engl J Med"},{"key":"R6-5-20210131","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":". Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"key":"R7-5-20210131","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/leu.2013.365","article-title":". Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.","volume":"28","author":"Martinez","year":"2014","journal-title":"Leukemia"},{"key":"R8-5-20210131","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":". The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"key":"R9-5-20210131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":". High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias.","volume":"46","author":"Waterfall","year":"2014","journal-title":"Nat Genet"},{"key":"R10-5-20210131","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.leukres.2012.11.021","article-title":". Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.","volume":"37","author":"Shao","year":"2013","journal-title":"Leuk Res"},{"key":"R11-5-20210131","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2011-09-379339","article-title":". Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.","volume":"119","author":"Xi","year":"2012","journal-title":"Blood"},{"key":"R12-5-20210131","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1182\/blood-2013-07-513523","article-title":". BRAF V600E is also seen in unclassifiable splenic B-cell lymphomaleukemia, a potential mimic of hairy cell leukemia.","volume":"122","author":"Raess","year":"2013","journal-title":"Blood"},{"key":"R13-5-20210131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/jmoldx.2006.050083","article-title":". FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.","volume":"8","author":"Ventura","year":"2006","journal-title":"J Mol Diagn"},{"key":"R14-5-20210131","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":". CCND2 rearrangements are the most frequent genetic events in cyclin D1() mantle cell lymphoma.","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"key":"R15-5-20210131","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":". Revised response criteria for malignant lymphoma.","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"R16-5-20210131","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2559.2009.03262.x","article-title":". Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural pattern.","volume":"54","author":"Petit","year":"2009","journal-title":"Histopathology"},{"key":"R18-5-20210131","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1827.2012.02844.x","article-title":". Malignant lymphoma of the spleen in Japan: a clinicopathological analysis of 115 cases.","volume":"62","author":"Shimizu-Kohno","year":"2012","journal-title":"Pathol Int"},{"key":"R19-5-20210131","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":". Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"R20-5-20210131","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":". Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"key":"R21-5-20210131","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/leu.2011.47","article-title":". High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia.","volume":"25","author":"Hockley","year":"2011","journal-title":"Leukemia"},{"key":"R22-5-20210131","first-page":"65","article-title":"t(9;14)(p13;q32) involving the PAX-5 gene: a unique subtype of 14q32 translocation in B cell non-Hodgkins lymphoma.","volume":"69","author":"Amakawa","year":"1999","journal-title":"Int J Hematol"},{"key":"R23-5-20210131","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/gcc.20214","article-title":". PAX5IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements.","volume":"44","author":"Poppe","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"R24-5-20210131","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1073\/pnas.91.26.12530","article-title":". Identification of the TCL1 gene involved in T-cell malignancies.","volume":"91","author":"Virgilio","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R25-5-20210131","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/modpathol.2008.148","article-title":". TCL1A expression delineates biological and clinical variability in B-cell lymphoma.","volume":"22","author":"Aggarwal","year":"2009","journal-title":"Mod Pathol"},{"issue":"suppl 2","key":"R26-5-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10428194.2011.565841","article-title":"Molecular variant of hairy cell leukemia with poor prognosis.","volume":"52","author":"Arons","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R27-5-20210131","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2012.3","article-title":". Over 30 of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.","volume":"26","author":"Bikos","year":"2012","journal-title":"Leukemia"},{"key":"R28-5-20210131","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2141.2009.07962.x","article-title":". Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns.","volume":"148","author":"Hockley","year":"2010","journal-title":"Br J Haematol"},{"key":"R29-5-20210131","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":". Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.","volume":"72","author":"Navarro","year":"2012","journal-title":"Cancer Res"},{"key":"R30-5-20210131","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":". Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.","volume":"110","author":"Bea","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R31-5-20210131","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":". Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.","volume":"208","author":"Fabbri","year":"2011","journal-title":"J Exp Med"},{"key":"R32-5-20210131","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":". Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.","volume":"119","author":"Kridel","year":"2012","journal-title":"Blood"},{"key":"R33-5-20210131","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/leu.2012.357","article-title":". NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.","volume":"27","author":"Villamor","year":"2013","journal-title":"Leukemia"},{"key":"R34-5-20210131","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/path.4428","article-title":". Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.","volume":"234","author":"Karube","year":"2014","journal-title":"J Pathol"},{"key":"R35-5-20210131","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1158\/1078-0432.CCR-13-0138","article-title":". Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.","volume":"19","author":"Ouillette","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R36-5-20210131","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1158\/1078-0432.CCR-07-1474","article-title":". Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia.","volume":"13","author":"Mansour","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R37-5-20210131","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":". Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"key":"R38-5-20210131","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":". High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis.","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"key":"R39-5-20210131","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.2012.09163.x","article-title":". The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.","volume":"158","author":"Hockley","year":"2012","journal-title":"Br J Haematol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000478-201602000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:00:49Z","timestamp":1786035649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-201602000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000523","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}